Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study

Autor: Bakker, Tinka, Klopotowska, Joanna E., de Keizer, Nicolette F., van Marum, Rob, van der Sijs, Heleen, de Lange, Dylan W., de Jonge, Evert, Abu-Hanna, Ameen, Dongelmans, Dave A., Hendriks, S., ten Cate, J., van Balen, D., Duyvendak, M., Karakus, A., Sigtermans, M., Kuck, E.M., Hunfeld, N.G.M., Spronk, P.E., van Kan, H.J.M., van der Steen, M.S., Bosma, B.E., Purmer, I., Kieft, H., Beishuizen, A., Movig, K., Vermeijden, J.W., Mulder, F., Bosman, R.J., Franssen, E.J.F., Wils, E.J., de Feiter, P.W., van den Bergh, W.M., Bult, W., Hoeksema, M., Wesselink, E.
Zdroj: Journal of Critical Care; June 2020, Vol. 57 Issue: 1 p134-140, 7p
Abstrakt: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intensive Care Unit (ICU). Computerized decision support systems (CDSSs) may help prevent DDIs by timely showing relevant warning alerts, but knowledge on which DDIs are clinically relevant in the ICU setting is limited. Therefore, the purpose of this study was to identify DDIs relevant for the ICU.
Databáze: Supplemental Index
Externí odkaz: